Response to neoadjuvant therapy in Breast cancer specimen Qualitative 85323-4
LOINC Code
| LOINC code | 85323-4 | ||
|---|---|---|---|
| name | Response to neoadjuvant therapy in Breast cancer specimen Qualitative | ||
| description | The response of the tumor to neoadjuvant treatment, such as chemotherapy or endocrine therapy. The response of invasive breast carcinoma to neoadjuvant therapy is associated with increased disease-free and overall survival. | ||
| status | ACTIVE | ||
Fully-Specified Name | |||
| component | Response to neoadjuvant therapy | ||
| property | Find = Finding | ||
| time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||
| system | Breast cancer specimen | ||
| scale | Ord = Ordinal: Ordered categorical responses, e.g., 1+, 2+, 3+; positive, negative; reactive, indeterminate, nonreactive. | ||
| method | |||
Additional Names | |||
| short name | Resp to neoadjvt therapy Br ca spec Ql | ||
Basic Attributes | |||
| class | PATH | ||
| type | 1 Laboratory | ||
| order vs. observation | Observation | ||
Associated Observations | |||
LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations. | |||
Member of these Panels | |||
| |||
History/Usage | |||
| first released | |||
| last updated | 2.61 | ||
| last change type | ADD - added | ||
Related Names | |||
| |||
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com